By Route of Administration

Venous Blood Draw (In-Clinic / Mobile Phlebotomy) Market Analysis

Cross-industry research covering Venous Blood Draw (In-Clinic / Mobile Phlebotomy) across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering Venous Blood Draw (In-Clinic / Mobile Phlebotomy)

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Venous draws are required for WES and WGS products seeking clinical-grade results, and are increasingly fulfilled through mobile phlebotomy services that preserve the consumer convenience proposition. This channel blurs the DTC/clinical boundary in ways that complicate FDA jurisdictional classification.

11%

Market Share

7.9%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments